Answers are grounded in this paper and cite their sources.
Background/Objectives: Immune checkpoint inhibitors (ICIs) are widely used in cancer treatment but can induce immune-related adverse events (irAEs), and real-world data from Saudi Arabia remain limited. We aimed to characterize the incidence, timing, and predictors of irAEs and their association with survival. Methods: We conducted a multicenter retrospective cohort study of adults who received at least one ICI dose at two tertiary centers in Riyadh (January 2017–January 2023; follow-up until July 2025). Physician-documented irAEs were extracted from medical records. Predictors were assessed using logistic regression, and progression-free survival (PFS) and overall survival (OS) were assessed using Kaplan–Meier methods, with a sensitivity analysis excluding isolated fatigue and a 3-month landmark analysis. Results: Among 608 patients (median age, 62 years; 55.9% male; 77.1% stage IV), 338 (55.6%) developed at least one irAE, most commonly fatigue (23.8%), endocrine events (15.3%), and skin reactions (10.2%). Median time to irAE onset was 84 days, with endocrine events occurring latest (median, 135 days). Hypertension was independently associated with irAE development (adjusted odds ratio, 1.58; 95% confidence interval, 1.04–2.40). Patients with irAEs had longer median PFS (14.26 vs. 6.08 months; p < 0.0001) and OS (26.14 vs. 16.91 months; p = 0.0324). The PFS association persisted after excluding isolated fatigue, whereas the OS association did not; neither was significant in the landmark analysis. Conclusions: In this real-world multicenter cohort, irAEs were common and showed distinct organ-specific onset patterns. Their associations with longer PFS and OS were attenuated after accounting for exposure definition and immortal time bias and should not be interpreted as evidence that irAEs predict treatment benefit.
No takes yet. Share an insight, caveat, or question.
Alanazi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: